4d Molecular Therapeutics In shares owned by Barclays
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $815k | 94k | 8.69 |
| 2025-06-30 | $415k | 112k | 3.72 |
| 2025-03-31 | $312k | 97k | 3.22 |
| 2024-12-31 | $586k | 105k | 5.57 |
| 2024-09-30 | $1.2M | 115k | 10.81 |
| 2024-06-30 | $1.0M | 48k | 20.99 |
| 2024-03-31 | $1.5M | 48k | 31.87 |
| 2023-12-31 | $2.2M | 109k | 20.26 |
| 2023-09-30 | $942k | 74k | 12.73 |
| 2023-06-30 | $2.6M | 143k | 18.07 |
| 2023-03-31 | $984k | 57k | 17.19 |
| 2022-12-31 | $770k | 35k | 22.20 |
| 2022-09-30 | $91k | 11k | 8.00 |
| 2022-06-30 | $68k | 9.6k | 7.03 |
| 2022-03-31 | $181k | 12k | 15.14 |